Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 25Breast 21Gastrointestinal 19Genitourinary 18Tumor-Agnostic 13Gynecologic 13Thoracic 12Other hematologic neoplasm 10Head & Neck 10Lymphoid 6Plasma cell 5Other 4Sarcoma 3Other neoplasm 2Endocrine 2Dermatologic 2CNS 2

Conditions

Melanoma 2Thyroid Cancer, Papillary 1Testicular Neoplasms 1Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Interviews as Topic × Dermatologic × Clear all
NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT00394134 2019-09-13

Targeted Intervention for Melanoma Prevention

M.D. Anderson Cancer Center

Phase NA Completed
205 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡